La terapia, que actúa como sustituto de una enzima natural, mejora la motricidad y desacelera la progresión de la enfermedad en etapas tempranas.
Read moreInvestigadores del IDIBAPS coordinan un estudio que demuestra el potencial de una nueva estrategia antifibrótica en enfermedades hepáticas crónicas. Se trata del papel de una enzima involucrada en ...
Read moreTelum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages, called enzybiotics, has ...
Read moreEl equipo de la investigadora Jennifer Doudna ha encontrado una nueva nucleasa Cas mucho más pequeña y versátil allí donde menos cabía esperar: en un virus. Este la ‘robó’ a una bacteria en ...
Read moreA UB study published in the journal Neurotherapeutics has validated a new pharmacological target for Alzheimer’s disease. The results show the inhibition of the enzyme soluble epoxide hydrolase (...
Read moreEl grupo de investigación del CiQUS de la Universidade de Santiago de Compostela (USC) dirigido por el Prof. José Luis Mascareñas consigue un nuevo impulso en el campo de la catálisis artificial e...
Read moreResearchers at the Institute for Bioengineering of Catalonia (IBEC) and the Catalan Institute of Nanoscience and Nanotechnology (ICN2) have developed a new type of encapsulated enzyme nanomotors.
Read moreLa compañía, basada en una tecnología del CSIC, dirige la evolución de estos catalizadores biológicos para mejor sus propiedades y aplicarlas en diversos sectores industriales
Read moreLatest advances in the framework of the SMART-4-FABRY project have been shared in both virtual events.
Read moreBig news for dealing with coronavirus and for the healthcare and life sciences sector in Catalonia: pharmaceutical company Reig Jofre, a member of CataloniaBio & HealthTech, has reached a deal with Ja...
Read moreAs chemical and life science companies seeking to monetize their IP portfolios emerge from the challenges of COVID-19, 2021 looks to be a year that will see increased product licensing, acquisitions a...
Read moreOn February 3, the final workshop of the European Smart4Fabry project will be held. Smart4Fabry is an initiative whose objective is to obtain a new GLA nanoformulation to address Fabry disease, achiev...
Read more